Bicara Therapeutics Inc. (BCAX)

NASDAQ: BCAX · Real-Time Price · USD

16.78

-0.02 (-0.12%)

Feb 27, 2026, 4:00 PM EST - Market closed

Bicara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 27, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	1,063	948	-	-
Enterprise Value	775	428	-	-
Last Close Price	16.78	17.42	-	-
PB Ratio	2.28	1.93	-	-
P/TBV Ratio	2.64	1.93	-	-
Debt / Equity Ratio	0.01	0.00	0.00	-
Net Debt / Equity Ratio	-0.72	-0.99	-1.05	0.24
Net Debt / EBITDA Ratio	2.04	5.94	5.76	0.11
Net Debt / FCF Ratio	2.55	6.54	4.97	0.13
Quick Ratio	13.80	27.22	15.28	0.17
Current Ratio	14.14	27.93	15.32	0.21
Return on Equity (ROE)	-26.64%	-19.14%	-51.67%	-
Return on Assets (ROA)	-18.59%	-13.84%	-20.72%	-
Return on Capital Employed (ROCE)	-35.00%	-16.70%	-18.20%	219.00%
Earnings Yield	-11.43%	-7.17%	-	-
FCF Yield	-10.63%	-7.89%	-	-
Buyback Yield / Dilution	-1559.37%	-2796.96%	-35.20%	-

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q